title: A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma.
abstract: OBJECTIVE
  A disintegrin and metalloprotease 12 (ADAM12) has multiple domains and functions, and it plays important roles in the development of cancer. We conducted a retrospective study to determine whether the expression of the membrane type of ADAM12 (ADAM12-L) could be a prognostic factor in resected pathological (p-) stage I lung adenocarcinoma.
  
  
  METHODS
  ADAM12-L mRNA expression was quantified by a reverse-transcription polymerase chain reaction in tissue samples from 84 completely resected p-stage I lung adenocarcinoma patients. The patients were divided into ADAM12-L-Low and ADAM12-L-High groups, and correlations with clinicopathologic features were obtained.
  
  
  RESULTS
  Five-year survival rates of the ADAM12-L-Low and ADAM12-L-High groups were 95.1% and 71.9%, respectively. The postoperative prognosis for the ADAM12-L-High group was significantly poorer than for the ADAM12-L-Low group (P = 0.006). Multivariate analysis confirmed that high expression of ADAM12-L was an independent factor for poor prognosis (P = 0.007, hazard ratio 8.288). The ADAM12-L-High group was less differentiated and had a significantly higher rate of cancer recurrence.
  
  
  CONCLUSIONS
  ADAM12-L mRNA expression is an independent prognostic factor in resected p-stage I lung adenocarcinoma, and is significantly correlated with tumor differentiation stage and postoperative cancer recurrence.
authors: Department of Thoracic Surgery, Kyoto University, Kyoto 606-8507, Japan.
authors: Nobuya
authors: N
authors: Mino
authors: Ryo
authors: R
authors: Miyahara
authors: Ei
authors: E
authors: Nakayama
authors: Tsuyoshi
authors: T
authors: Takahashi
authors: Ayuko
authors: A
authors: Takahashi
authors: Shotaro
authors: S
authors: Iwakiri
authors: Makoto
authors: M
authors: Sonobe
authors: Kenichi
authors: K
authors: Okubo
authors: Toshiki
authors: T
authors: Hirata
authors: Atsuko
authors: A
authors: Sehara
authors: Hiroshi
authors: H
authors: Date
mesh_terms: D051722:ADAM Proteins / Q000235:genetics* / Q000378:metabolism; D000072199:ADAM12 Protein; D000230:Adenocarcinoma / Q000235:genetics / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D045744:Cell Line, Tumor; D019483:Disintegrins / Q000235:genetics* / Q000378:metabolism; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D008297:Male; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D008875:Middle Aged; D015999:Multivariate Analysis; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D012333:RNA, Messenger / Q000378:metabolism; D012189:Retrospective Studies; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D019483:Disintegrins; D008565:Membrane Proteins; D012333:RNA, Messenger; D051722:ADAM Proteins; D000072199:ADAM12 Protein; C000606480:ADAM12 protein, human